|
1. |
Dr. Purvish M. Parikh |
2023 |
Purvish M. Parikh, Rapid incorporation of technology in health-care management – Blessing or curse? Indian Journal of Medical Sciences • Volume 75 • Issue 3 • September-December 2023:103-6 |
|
2. |
Dr. Purvish M. Parikh |
2023 |
Purvish M. Parikh Ayurvedic Doctors Cannot Prescribe Allopathic Medicines—National Consumer Dispute Redressal Commission Judgement. South Asian J Cancer 2023;00 (00):00–00 |
|
3. |
Dr. Purvish M. Parikh |
2023 |
P.M. Parikh1 S. Aggarwal2 G. Biswas3 S. Gulia4 V. Agarwala5 M. Basade6 P.N. Mohapatra7 K. Muddu Vamshi8 A. Warrier9 Krishna Prasad10 Partha Roy11 M.V. handrakant12 H. Malhotra13 Sachin. Practical Clinical Consensus Guidelines for the Management of Cancer Associated Anemia (CAA) in Low- and Middle-Income Countries (LMIC). South Asian J Cancer 2023;00(00):00–00 (Open Access) |
|
4. |
Dr. Purvish M. Parikh |
2023 |
Parikh, PM (Parikh, Purvish M. M.) . ChatGPT—Preliminary Overview with Implications for Medicine and Oncology. Ind J Med Paediatr Oncol 2023;44:377–83. |
|
5. |
Dr. Purvish M. Parikh |
2023 |
Dr. Purvish M. Parikh. Unmet Needs in Geriatric Oncology. South Asian J Cancer 2023;00 (00):00–00(Thieme Open Access) |
|
6. |
Dr. Purvish M. Parikh |
2023 |
Dr. Purvish M. Parikh. Consensus guidelines for the management of HR-positive HER2/neu negative early breast cancer in India, SAARC region and other LMIC by DELPHI survey method (Research). BMC Cancer (2023) 23:714; pg1-11 Open Access |
|
7. |
Dr. Purvish M. Parikh |
2023 |
Purvish M. Parikh1 Dinesh M. Shah2 Urvish G. Parikh3 Ajit Venniyoor4 Govind Babu5 Apurva Garg6 Hemant Malhotra7. ChatGPT—Preliminary Overview with Implications for Medicine and Oncology. Ind J Med Paediatr Oncol (Open Access) |
|
8. |
Dr. Purvish M. Parikh |
2023 |
Parikh PM,. Judge Juan Manuel Padilla Garcia, ChatGPT, and a controversial medicolegal milestone. Indian J Med Sci 2023;75:3-8. |
|
9. |
Dr. Purvish M. Parikh |
2023 |
Parikh PM,, Cervical Cancer HPV Vaccination and Bhutan. South Asian J Cancer.2023 Jan; 12(1): 41–43. |
|
10. |
Dr. Purvish M. Parikh |
2023 |
Parikh PM,, Prevention of Cervical Cancer through HPV Vaccination and Screening in Maldives. South Asian J Cancer. 2023 Jan; 12(1): 44–46. Published online 2023 Feb |
|
11. |
Dr. Purvish M. Parikh |
2023 |
Parikh PM,, Challenges in Cervical Cancer Prevention: Real-World Scenario in India. South Asian J Cancer. 2023 Jan; 12(1): 9–16. |
|
12. |
Dr. Purvish M. Parikh |
2023 |
Parikh PM,. Cervical Cancer in SAARC Countries. South Asian J Cancer. 2023 Jan; 12(1): 1–8. |
|
13. |
Dr. Purvish M. Parikh |
2023 |
Parikh PM,. Lung cancer immunotherapy: progress, pitfalls, and promises. Mol Cancer. 2023; 22: 40. |
|
14. |
Dr. Purvish M. Parikh |
2023 |
Parikh PM,. Who are the real parasite publishers and journals? What prevents all medical data from being open access in real-time?. Indian Journal of Medical Sciences • Volume 74 • Issue 3 • September-December 2022 |
|
16 |
Dr. Purvish M. Parikh |
2022 |
Purvish Parikh1, Hemant Malhotra2, Lalit Mohan Sharma2, Ajay Yadav2, Naveen Gupta1. Editorial. Int J Mol Immuno Oncol 2022;3:61-3. |
|
17 |
Dr. Purvish M. Parikh |
2022 |
Abhiram Kumar, Kalyani Sakhare, Dwaipayan Bhattacharya, Raktim Chattopadhyay, Purvish Parikh. Communication in non-communicable diseases (NCDs) and role of immunomodulatory nutraceuticals in their management. Front Nutr. 2022; 9: 966152. Published online 2022 Sep 21 |
|
18 |
Dr. Purvish M. Parikh |
2022 |
Parikh P, Aggarwal IB, Daddi A, Narasimhan PN, DSouza HH, Agarwal V, et al. Ibrutinib and atrial fibrillation as cardiotoxicity – A new safety warning that impacts overall survival. Int J Mol Immuno Oncol 2022;2:54-7. |
|
19 |
Dr. Purvish M. Parikh |
2022 |
Amol Patel , Amol Akhade, Purvish Parikh, Atul Sharma, Hemant Malhotra, Kumar Prabhash. Pembrolizumab weight based dosing - A call for policy change. Indian J Med Paediatr Oncol 2022; 43(03): 306-10 |
|
20 |
Dr. Naveen Gupta |
2022 |
Purvish Parikh1, Hemant Malhotra2, Lalit Mohan Sharma2, Ajay Yadav2, Naveen Gupta1. Editorial. Int J Mol Immuno Oncol 2022;3:61-3. |
|
21 |
Dr. Naveen Gupta |
2022 |
Dr. Naveen Gupta, Review Article- Clinical application of molecular genetics in acute myeloid leukemia. Int J Mol Immuno Oncol 2022;3:102-7. |
|
22 |
Dr. Naveen Gupta |
2022 |
Priyanka Soni, Naveen Gupta, Hemant Malhotra. The day 14 conundrum still remains unresolved!. Cancer Research, Statistics, and Treatment. 5(1):p 155-6, Jan–Mar 2022.( Letters to Editor) |
|
23 |
Dr. Naveen Gupta |
2022 |
Dr. Naveen Gupta. Challenges in Cervical Cancer Prevention: Real-World Scenario in India. South Asian J Cancer 2023 Feb 25;12(1):9-16 |
|
24 |
Dr. Lalit Mohan Sharma |
2023 |
Dr. Lalit Mohan Sharma. Challenges in Cervical Cancer Prevention: Real-World Scenario in India. South Asian J Cancer 2023 Feb 25;12(1):9-16 |
|
25 |
Dr. Lalit Mohan Sharma |
2022 |
Purvish Parikh1, Hemant Malhotra2, Lalit Mohan Sharma2, Ajay Yadav2, Naveen Gupta1. Editorial. Int J Mol Immuno Oncol 2022;3:61-3. |
|
26 |
Dr. Priyanka Soni |
2022 |
Priyanka Soni1 Sandeep Jain1 Gauri Kapoor1 Gayatri Vishwakarma2. Dual-Energy X-Ray Absorptiometry and Anthropometry for Assessment of Nutritional Status at Diagnosis in Children with Cancer: A Single-Center Experience from India. South Asian J Cancer . 2022 Dec 2;11(2):164-71 |
|
27 |
Dr. Priyanka Soni |
2022 |
Priyanka Soni, Naveen Gupta, Hemant Malhotra. The day 14 conundrum still remains unresolved!. Cancer Research, Statistics, and Treatment. 5(1):p 155-6, Jan–Mar 2022.( Letters to Editor) |